SCHEMBL24893151

SCHEMBL24893151

NCCNC(=O)CNC(=O)CCC(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PHF8 Q9UPP1 5/20 0.45
KDM2A Q9Y2K7 5/20 0.45
KDM4E B2RXH2 3/20 0.45
KDM5C P41229 3/20 0.45
EGLN1 Q9GZT9 3/20 0.41
KDM6B O15054 1/20 0.41
FOLH1 Q04609 1/20 0.41
ECE1 P42892 1/20 0.39
KMT2A Q03164 2/20 0.38
GABRR1 P24046 2/20 0.38
LMNA P02545 2/20 0.38
GABRR3 A8MPY1 1/20 0.38
GABRP O00591 1/20 0.38
GABRD O14764 1/20 0.38
HDAC3 O15379 1/20 0.38
GABBR2 O75899 1/20 0.38
CYP1A2 P05177 1/20 0.38
THRB P10828 1/20 0.38
GABRA1 P14867 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL766363 0.92 PHF8 (0.52) PHF8KDM2AKDM4EKDM5CEGLN1
SCHEMBL19776948 0.89 KMT2A (0.45) PHF8KDM2AKDM4EKDM5CEGLN1
SCHEMBL14785792 0.83 EPHX2 (0.45) PHF8KDM2AKDM4EKDM5CEGLN1
SCHEMBL14785649 0.83 EPHX2 (0.49) PHF8KDM2AKDM4EKDM5CEGLN1
SCHEMBL38654455 0.82 ALDH1A1 (0.42) KDM4EKMT2ALMNACYP1A2TSHR
SCHEMBL490860 0.82 KDM4E (0.46) PHF8KDM2AKDM4EKDM5CEGLN1
SCHEMBL9999327 0.82 KDM4E (0.46) PHF8KDM2AKDM4EKDM5CEGLN1
SCHEMBL14785685 0.82 PRMT1 (0.52) PHF8KDM2AKDM4EKDM5CEGLN1
SCHEMBL14785825 0.82 PRMT1 (0.52) PHF8KDM2AKDM4EKDM5CEGLN1
SCHEMBL14785620 0.82 PRMT1 (0.52) PHF8KDM2AKDM4EKDM5CEGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023288226-A2 POLYMER ENGINEERED FORMS OF INTERFERON-GAMMA AND METHODS OF USE NEKTAR THERAPEUTICS (US) 2023-01-19 WO disclosed